Sage Therapeutics, Inc. Insider Trading for December 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sage Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sage Therapeutics, Inc. for December 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 26 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 50,000 | 22,500 | 232,552 | |
Dec 26 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 50,000 | 22,500 | 51,226 | 1.2 K to 51.2 K (+4,078.30 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 12,753 | 5,739 | 282,552 | |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 110,247 | 49,611 | 295,305 | |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 155.00 | 12,753 | 1,976,715 | 1,226 | 14 K to 1.2 K (-91.23 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 12,753 | 5,739 | 13,979 | 1.2 K to 14 K (+1,040.21 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 162.59 | 599 | 97,391 | 1,226 | 1.8 K to 1.2 K (-32.82 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 162.08 | 5,000 | 810,400 | 1,825 | 6.8 K to 1.8 K (-73.26 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 160.36 | 13,049 | 2,092,538 | 6,825 | 19.9 K to 6.8 K (-65.66 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 159.53 | 22,334 | 3,562,943 | 19,874 | 42.2 K to 19.9 K (-52.91 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 158.21 | 33,301 | 5,268,551 | 42,208 | 75.5 K to 42.2 K (-44.10 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 157.48 | 27,152 | 4,275,897 | 75,509 | 102.7 K to 75.5 K (-26.45 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 156.55 | 71,823 | 11,243,891 | 102,661 | 174.5 K to 102.7 K (-41.16 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 155.48 | 36,989 | 5,751,050 | 174,484 | 211.5 K to 174.5 K (-17.49 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 110,247 | 49,611 | 211,473 | 101.2 K to 211.5 K (+108.91 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 163.93 | 1,021 | 167,373 | 94,259 | 95.3 K to 94.3 K (-1.07 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 162.21 | 700 | 113,547 | 95,280 | 96 K to 95.3 K (-0.73 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 161.40 | 6,187 | 998,582 | 95,980 | 102.2 K to 96 K (-6.06 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 160.12 | 21,410 | 3,428,169 | 102,167 | 123.6 K to 102.2 K (-17.33 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 159.46 | 8,734 | 1,392,724 | 123,577 | 132.3 K to 123.6 K (-6.60 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 158.18 | 16,748 | 2,649,199 | 132,311 | 149.1 K to 132.3 K (-11.24 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 157.27 | 3,700 | 581,899 | 149,059 | 152.8 K to 149.1 K (-2.42 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 156.31 | 1,500 | 234,465 | 152,759 | 154.3 K to 152.8 K (-0.97 %) |